Caris Life Sciences' Q2 featured accelerating clinical volumes, 68% gross margin, and strong early traction for Caris Detect.

SELLAS Life Sciences is rated Hold, with a $9.25 price target, as current valuation already reflects high REGAL trial success ...

Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership for LabVantage.

CND Life Sciences, Inc. (CND), a medical technology company that advances neurodiagnostic tests and associated biomarker ...

Research is a Team EffortIn the past, research was generally something done alone. Mendel, too, was diligently sowing beans by himself in his monastery garden. However, in modern life science research ...

Anthropic's new Life Sciences Verification Program gives qualifying organizations gated access to its Mythos 5.1 model for ...

The companies that successfully raise money increasingly aren’t just those with the best research or technology. They are ...

Rubedo Life Sciences, Inc. (Rubedo) today announced a new clinical study of investigational RLS-1496 in patients with ...

This article is an unofficial Japanese translation based on an Anthropic article, and all copyrights and intellectual ...

The conversation focused on how a reliable patent system supports the journey from scientific discovery to patient access.

Sai Life Sciences Ltd is quoting at Rs 1617, up 1.03% on the day as on 12:49 IST on the NSE. The stock is up 84.95% in last one year as compared to a 7.1% gain in NIFTY and a 20.91% gain in the Nifty ...

Plus: Billionaires push psychedelic treatments; investor Agora makes first deal ...